Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$146,705,893
+$38,671,549 QoQ
Shares Held
122,313
+4.1% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#312
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealthfront Advisers LLC holds $426,565,397 across 11 Drug Manufacturers - General names. LLY ranks #1 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
122,313 | $146,705,893 | |
| 2 | JNJ |
Johnson & Johnson
|
337,182 | $85,634,112 | |
| 3 | ABBV |
AbbVie Inc.
|
190,484 | $47,933,393 | |
| 4 | MRK |
Merck & Co., Inc.
|
317,659 | $40,819,181 | |
| 5 | AMGN |
Amgen Inc
|
84,152 | $30,473,122 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
239,441 | $30,250,975 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
417,877 | $24,078,072 | |
| 8 | PFE |
Pfizer Inc
|
672,665 | $16,197,773 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $146,705,893 | 122,313 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $108,034,344 | 117,458 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $123,889,121 | 115,280 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $84,401,534 | 110,618 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $82,405,675 | 105,712 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $91,898,179 | 111,269 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $80,792,116 | 104,653 | Shares | Sole | 2025-04-01 | |
| 2024-09-30 | $92,000,439 | 103,845 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $95,261,367 | 105,217 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $82,578,120 | 106,147 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $62,201,644 | 106,707 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $57,029,240 | 106,174 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $50,829,459 | 108,383 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $36,544,695 | 106,414 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $40,761,892 | 111,420 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $35,577,877 | 110,029 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,763,292 | 107,218 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $23,858,916 | 83,315 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $18,923,555 | 68,509 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $13,930,466 | 60,292 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $12,535,005 | 54,614 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $9,591,151 | 51,339 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,841,436 | 46,443 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,683,866 | 51,911 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $8,376,135 | 51,018 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $6,599,049 | 47,571 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||